The three measurements were:
-- Prescribing Angiotensin-Converting Enzyme (ACE) Inhibitor or
Angiotensin Receptor Blocker (ARB) Therapy for adult patients with a
diagnosis of heart failure and left ventricular systolic dysfunction
(LVSD);
-- Prescribing oral antiplatelet therapy for adult patients with a
diagnosis of coronary artery disease; and,
-- Prescribing beta-blocker therapy adult patients with a diagnosis of
coronary artery disease and prior myocardial infarction (MI).
"That's where Ingenious Med and IM Quality Measures(TM) came in," said Torcson. "There were other PQRI performance measures related to stroke and advanced care plans available for hospitalists, but the cardiac measures were the most commonly reported and also harmonized with the Joint Commission Core Measures already reported by hospitals. SHM was given an opportunity to present a position paper to CMS and make a case for keeping the three cardiac inpatient measures. Using data from IM Quality Measures(TM) provided by Ingenious Med, SHM was able to show that these were not only pertinent measures, but also were the most common measures reported by hospitalists and that these inpatient measures harmonized very nicely with hospital-level performance measures."
CMS decided not to change the specifications. This decision was very favorable for hospital medicine, Torcson said.
"Hospital medicine as a distinct specialty really rose out of the drive
for efficiency, particularly on the inpatient side," he explained.
"Hospitalists operate in an environment that is focused on performance
measurement and improvement. It is the basis of what hospitalists do. Now
that we're at the beginning of the era of pay-for-performance, we wanted
hospitalists to develop their performance reporting skills, and the cardiac
measures are very impo
'/>"/>
| SOURCE Ingenious Med Copyright©2008 PR Newswire. All rights reserved |